Board Meeting20 Jul 2026, 12:55 pm
Zydus Lifesciences Board Meeting on Aug 11 to Approve Unaudited Results
AI Summary
Zydus Lifesciences Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda item for this meeting is the consideration and approval of the unaudited financial results for the quarter ending June 30, 2026. Additionally, the company has informed about the closure and reopening of the trading window for its directors and designated persons, in compliance with SEBI regulations. The trading window will be closed until August 13, 2026, and will reopen on August 14, 2026.
Key Highlights
- Board meeting scheduled for August 11, 2026.
- To consider and approve unaudited financial results.
- Results pertain to the quarter ended June 30, 2026.
- Trading window closure and reopening dates announced.
- Compliance with SEBI (Prohibition of Insider Trading) Regulations.
Price Impact
More from ZYDUSLIFE